标题
New strategies for the treatment of breast cancer with leptomeningeal metastasis
作者
关键词
-
出版物
CURRENT OPINION IN ONCOLOGY
Volume 35, Issue 6, Pages 500-506
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2023-10-12
DOI
10.1097/cco.0000000000000988
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases
- (2023) Anna-Maria Lazaratos et al. BREAST
- Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial
- (2023) Fabrice André et al. LANCET
- Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results
- (2023) Isabella C. Glitza Oliva et al. NATURE MEDICINE
- Quantitative assessment of circulating tumor cells in cerebrospinal fluid as a clinical tool to predict survival in leptomeningeal metastases
- (2022) Maria Diaz et al. JOURNAL OF NEURO-ONCOLOGY
- Trastuzumab Deruxtecan in Patients with Central Nervous System Involvement from HER2-Positive Breast Cancer: The DEBBRAH Trial
- (2022) José Manuel Pérez-García et al. NEURO-ONCOLOGY
- Immune Checkpoint Inhibitors in the Treatment of Breast Cancer Brain Metastases
- (2022) Ilana Schlam et al. ONCOLOGIST
- Detection of Circulating Tumor Cells in Cerebrospinal Fluid of Patients with Suspected Breast Cancer Leptomeningeal Metastases: A Prospective Study
- (2022) Amélie Darlix et al. CLINICAL CHEMISTRY
- Randomized Phase II Trial of Proton Craniospinal Irradiation Versus Photon Involved-Field Radiotherapy for Patients With Solid Tumor Leptomeningeal Metastasis
- (2022) Jonathan T. Yang et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial
- (2022) Rupert Bartsch et al. NATURE MEDICINE
- Phase II study of intrathecal administration of trastuzumab in patients with HER2-positive breast cancer with leptomeningeal metastasis
- (2022) Florence Oberkampf et al. NEURO-ONCOLOGY
- A Phase I/II Study of Intrathecal Trastuzumab in HER-2 Positive Cancer with Leptomeningeal Metastases: Safety, Efficacy, and Cerebrospinal Fluid Pharmacokinetics
- (2022) Priya U Kumthekar et al. NEURO-ONCOLOGY
- Leptomeningeal Metastases: New Opportunities in the Modern Era
- (2022) Jessica A. Wilcox et al. Neurotherapeutics
- Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
- (2022) Shanu Modi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer
- (2022) Javier Cortes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Radiotherapy for Leptomeningeal Carcinomatosis in Breast Cancer Patients: A Narrative Review
- (2022) Ewa Pawłowska et al. Cancers
- Systemic Therapy Approaches for Breast Cancer Brain and Leptomeningeal Metastases
- (2022) Ajay Dhakal et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
- (2022) Sara A Hurvitz et al. LANCET
- Incidence proportion and prognosis of leptomeningeal disease among patients with breast vs. non-breast primaries
- (2022) Nayan Lamba et al. NEURO-ONCOLOGY
- Ventriculoperitoneal Shunt for CNS Metastasis in Breast Cancer: Clinical Outcomes Based on Intrinsic Subtype
- (2021) Hee Kyung Kim et al. Clinical Breast Cancer
- A systematic review of craniospinal irradiation for leptomeningeal disease: past, present, and future
- (2021) L. Maillie et al. Clinical & Translational Oncology
- Clinical outcomes in patients (pts) with a history of central nervous system (CNS) metastases receiving talazoparib (TALA) or physician’s choice of chemotherapy (PCT) in the phase 3 EMBRACA trial.
- (2021) Jennifer Keating Litton et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkers
- (2021) Jarushka Naidoo et al. Journal for ImmunoTherapy of Cancer
- Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases in a large real-life database
- (2021) M. Carausu et al. ESMO Open
- Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis
- (2021) Priscilla K. Brastianos et al. Nature Communications
- ANG1005, a brain penetrating peptide-drug conjugate, shows activity in patients with breast cancer with leptomeningeal carcinomatosis and recurrent brain metastases
- (2020) Priya Kumthekar et al. CLINICAL CANCER RESEARCH
- Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis
- (2020) Priscilla K. Brastianos et al. NATURE MEDICINE
- Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial☆
- (2020) F. Montemurro et al. ANNALS OF ONCOLOGY
- A Phase 2 Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor Positive Breast Cancer
- (2020) Sara M Tolaney et al. CLINICAL CANCER RESEARCH
- Clinical Trial of Proton Craniospinal Irradiation for Leptomeningeal Metastases
- (2020) T Jonathan Yang et al. NEURO-ONCOLOGY
- Prognostic validation and clinical implications of the EANO ESMO classification of leptomeningeal metastasis from solid tumors
- (2020) Emilie Le Rhun et al. NEURO-ONCOLOGY
- Continued endocrine therapy is associated with improved survival in patients with breast cancer brain metastases
- (2019) Elisabeth Sophie Bergen et al. CLINICAL CANCER RESEARCH
- Clinical outcome of cerebrospinal fluid shunts in patients with leptomeningeal carcinomatosis
- (2019) Hye Seon Kim et al. World Journal of Surgical Oncology
- TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases
- (2019) Rachel A. Freedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study of Intermittent High-Dose Lapatinib Alternating with Capecitabine for HER2-Positive Breast Cancer Patients with Central Nervous System Metastases
- (2019) Aki Morikawa et al. CLINICAL CANCER RESEARCH
- Radiotherapy in Leptomeningeal Disease: A Systematic Review of Randomized and Non-randomized Trials
- (2019) Samantha M. Buszek et al. Frontiers in Oncology
- Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
- (2019) Rashmi K. Murthy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer
- (2019) Shanu Modi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA
- (2014) I. E. Krop et al. ANNALS OF ONCOLOGY
- Ommaya reservoir-related infections: Clinical manifestations and treatment outcomes
- (2013) Ariel D. Szvalb et al. JOURNAL OF INFECTION
- Ommaya reservoir infections: A 16-year retrospective analysis
- (2013) Peter A. Mead et al. JOURNAL OF INFECTION
- Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study
- (2012) Thomas Bachelot et al. LANCET ONCOLOGY
- Ventriculoperitoneal shunt for hydrocephalus caused by central nervous system metastasis
- (2011) Seung Hoon Lee et al. JOURNAL OF NEURO-ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search